Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: Results of a randomized, double‐blind, placebo‐controlled trial

201087 citationsJournal Article

Authors

Lesley M. Arnold · University of Cincinnati Medical Center

Abstract

Milnacipran administered at a dosage of 100 mg/day improved pain, global status, fatigue, and physical and mental function in patients with fibromyalgia.

Topics & Keywords

Fibromyalgia and Chronic Fatigue Syndrome Research Musculoskeletal pain and rehabilitation Pain Management and Placebo Effect

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Arthritis & Rheumatism

Volume 62, Issue 9, pp. 2745-2756

DOI: 10.1002/art.27559

Field-Weighted Citation Impact: 7.34